Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

RISE Registry Helps ACR Members Successfully Navigate MIPS

David I. Daikh, MD, PhD  |  Issue: April 2018  |  April 26, 2018

EtiAmmos / shutterstock.com

EtiAmmos / shutterstock.com

Time certainly flies, and 2018 marks the second year that rheumatologists who see Medicare patients are operating under the new Quality Payment Program (QPP) created by the Medicare Access & CHIP Reauthorization Act (MACRA). MACRA repealed the Fee-for-Service model under the Sustainable Growth Rate (SGR) formula and transitioned Medicare reimbursement to a system more overtly focused on quality and value of care.

The QPP has two pathways in which providers will be reimbursed for their Medicare Part B payments:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  1. Merit-Based Incentive Payment System (MIPS) and
  2. Alternative Payment Models (APMs).

Beyond the usual adjustments that are required in response to the Centers for Medicare & Medicaid Services (CMS) and other administrative regulators of our practices, the QPP requires a major shift in how we think about demonstrating value in our practices.

According to the CMS, 5,629 rheuma­tologists must participate in the QPP in the first performance year.1 The ACR is working to provide options for rheumatologists to use either pathway. The APM represents a more significant change from the traditional payment model, and the ACR has funded the development of a rheumatology APM that is currently in the testing phase. However, at this point, an overwhelming majority of rheumatologists will participate in the QPP via the MIPS pathway. With data requirements increasing for MIPS in 2018, rheuma­tologists must have a plan in place early for their reporting. Depending on what percentage of your practice is made up of Medicare Part B patients in 2018, the resulting 5% bonus/penalty can obviously be significant.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Rheumatologists can choose various reporting mechanisms to participate in MIPS, and it’s important to note that—among the options—MACRA created incentives for providers to report via registries—including significant bonuses for reporting via a Qualified Clinical Data Registry (QCDR). The ACR has operated its own QCDR, the Rheumatology Informatics System for Effectiveness (RISE), as a member benefit since 2014. RISE helped rheumatologists meet the quality reporting requirements of the now-discontinued Physician Quality Reporting System (PQRS) and can help you meet your current requirements under MIPS.

RISE established a great record of success for rheumatology in the 2017 performance year, and as a result of the increased reporting requirements and rapidly expanding participation in the registry, RISE will be even more valuable for rheumatologists in the 2018 per­formance year. Early adopters of RISE have demonstrated that they have a significant head start over their other rheumatology colleagues. If you would like to join the RISE registry and use it as your reporting option for 2018, register now.

MIPS Mechanics

MIPS scores the care we provide via four performance categories:

  1. Quality;
  2. Improvement activities;
  3. Advancing care information; and
  4. Cost

These are combined to generate a final MIPS Composite Score, which CMS uses to assess payment penalties/bonuses.

Page: 1 2 3 | Single Page
Share: 

Filed under:President's Perspective Tagged with:ACR Rise RegistryAmerican College of Rheumatology (ACR)MACRAMIPS

Related Articles

    2023 Medicare Physician Fee Schedule Final Rule for Quality Payment Program Published

    January 6, 2023

    The ACR highlights essential policy and reporting changes to the Quality Payment Program for performance year 2023 and beyond. Key changes include policies regarding the development of new MIPS Value Pathways and refinement of subgroup participation.

    2024 Proposed Rule for the Quality Payment Program Released

    August 17, 2023

    See key changes for the Merit-Based Incentive Payment System for the 2024 performance year as outlined in the proposed rule.

    2022 PFS Final Rule for the Quality Payment Program Published

    December 2, 2021

    The ACR highlights essential information for providers for 2022 MIPS reporting in the 2022 Medicare Physician Fee Schedule Final Rule, published Nov. 2.

    Providers Using RISE Have Advantage with 2017 MIPS Reporting

    March 15, 2018

    Hundreds of rheumatology providers across the country are finalizing submissions for the first year of reporting under the Merit-Based Incentive Payment System (MIPS). According to a presentation at the 2017 ACR/ARHP Annual Meeting in San Diego, providers that participate in and submit through the Rheumatology Informatics System for Effectiveness (RISE) Registry are poised to perform…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences